Creating Value by Transforming the Consumer Health Experience
Total Page:16
File Type:pdf, Size:1020Kb
Creating Value by Transforming the Consumer Health Experience Larry Merlo President & Chief Executive Officer Cautionary statement regarding forward-looking statements The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled “Cautionary Statement Concerning Forward-Looking Statements” in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The presentations at our 2019 Investor Day include non-GAAP financial measures that we use to describe our company’s performance. In accordance with SEC regulations, you can find the definitions of these non-GAAP measures, as well as reconciliations to most comparable GAAP measures, on the Investor Relations portion of our website. Link to our non-GAAP reconciliations. 2 Today’s Objectives Strength of our businesses and how they provide a foundation for transformation How we intend to dramatically improve the way health care is delivered in the U.S. Our expectations for 2020 / 2021 and our positioning for long-term growth How current investments will translate into increased shareholder value 3 Agenda Key trends in health care Well positioned to drive change Enterprise priorities to accelerate growth 4 As health care challenges mount, the call for change grows louder 5 Trends driving change in the health care landscape Empowered Migration Changing Evolution of Evolving health care from sick care perspectives personalized payment consumer to self care on aging care models 6 Agenda Key trends in health care Well positioned to drive change Enterprise priorities to accelerate growth 7 Creating the most consumer-centric health company Powerful health Owner economics Recognized and Deep local footprint care decision- enable broader ability trusted brand, of consumer-facing making engine to deliver value supported by large assets including informed by data across enterprise workforce of clinicians retail stores and and analytics and support MinuteClinic® professionals 8 Unmatched ability to engage with consumers – CVS Health interacts with one in three Americans annually In the community In the home In the palm of their hand of U.S. population lives visits1 patients enrolled in ~70% within three miles of a 700K annually 72M text messaging CVS Pharmacy program 9 We are uniquely positioned among managed care peers Competitor Competitor Competitor 1 2 3 Medical benefits Pharmacy benefits Specialty pharmacy Retail pharmacy Unmatched local consumer Retail clinics touchpoints Other providers/services 10 Agenda Key trends in health care Well positioned to drive change Enterprise priorities to accelerate growth 11 1. 2. Grow and Deliver Enterprise priorities to differentiate our transformational accelerate growth businesses products and services Consumer obsessed – be local, make it simple, improve health 3. 4. Create a consumer- Modernize enterprise centric technology functions and infrastructure capabilities 12 PRIORITY #1 Grow and differentiate our businesses Deliver new Drive Introduce Win in and innovative Improve engagement integrated high-growth benefit designs, productivity through products market reimbursement and efficiency personalization and services segments models, and store formats 13 HealthHUBs®: Positive Results Fuel Broader Expansion By the end Expanding to of 2019 4 markets By the end Expecting to open of 2021 1,500 locations 14 PRIORITY #2 Transformation provides multiple growth opportunities Products & Value Creation Operating Income Services Expectations2 Medical cost savings Comprehensive chronic care ~ $850 million and disease management Membership growth in 2022 New consumer facing products Optimize government programs Expanded use of CVS assets ~ $2.5 billion Risk carve-outs long term Increased customer Home hemodialysis satisfaction and retention Analytics products Open platform and new businesses 15 PRIORITY #3 Creating a consumer-centric technology infrastructure Seamless, connected digital Turning data into and physical insights and experiences insights into action Consumer-centric Simplify the experience Improve outcomes Drive efficiency An intelligent engagement platform 16 PRIORITY #4 Integration and Integration Enterprise modernization synergies modernization • Business integration • Technology expected to enhancements • General and deliver administrative functions • Productivity improvements significant • Medical cost savings savings On track to deliver savings of Targeting savings of ~ $900M 2 $1.5B-2.0B2 in 2021 and beyond in 2022 and beyond 17 Enterprise priorities create path to accelerate growth 2022+ Low double digits 2021 Mid single digits 2020 Low single Projected Adjusted digits EPS growth (%)2,3 2019 $6.75 to $6.90 18 Our commitment to shareholders Consistent vision and strategy Relentless focus on execution across the enterprise Disciplined investment decisions and thoughtful portfolio evaluation Delivering superior returns 19 Advancing the Enterprise Driving Profitable Growth as a to Unlock Value Consumer Health Company Eva Boratto Karen Lynch Today’s Building the Most Consumer- Evolving Strategy for a Changing Centric Health Company Marketplace agenda Alan Lotvin, MD Derica Rice Establishing the Foundation Consumer Innovation Driving for Transformation Profitable Growth Jon Roberts Kevin Hourican 20 Endnotes 1. Number of in-home visits includes visits by Coram, Aetna, and vendor nurses or other care team members to homes or other community settings. 2. Currently enacted laws and regulations were used in all the Company’s projections. 3. This financial measure is a non-GAAP financial measure. For an explanation of this financial measure and a reconciliation to the most directly comparable GAAP measure, refer to our Investor Relations website at https://www.investors.cvshealth.com. 21 Advancing the Enterprise to Unlock Value Eva Boratto Executive Vice President & Chief Financial Officer Continued focus on enhancing long-term shareholder value Optimizing capital allocation Generating significant cash flow from operations Launching transformative products Sustainable long-term Steps of value creation growth to drive long-term growth 2 Agenda 2019 guidance review Value creation through integration synergies, modernization & transformation Financial outlook & capital allocation strategy 3 Enterprise Outlook: 2019 full year1 Reaffirming all elements of 2019 guidance ($ in billions, except per share data) Consolidated Revenues $251.2 to $254.4 Adjusted Operating Income3 $15.0 to $15.2 GAAP Diluted EPS $4.90 to $5.05 3 Adjusted EPS $6.75 to $6.90 Cash Available to Repay Debt3 $4.2 to $4.6 4 Agenda 2019 guidance review Value creation through integration synergies, modernization & transformation Financial outlook & capital allocation strategy 5 1 1. INTEGRATION SYNERGIES Executing on integration synergies to reach ~$900M run rate ~$900M Business integration ~$800M . Plan design . Specialty / Coram / PBM Operations / Other General & administrative functions . Vendor contracting $300-$350M . Streamline corporate functions Medical cost savings . Improve adherence and close gaps in care for patients with chronic diseases . Optimize existing programs in readmission prevention 2019P 2020P Run Rate . Site of care management 2021P+ Business General & Medical integration administrative cost savings functions 6 2. ENTERPRISE MODERNIZATION Generating net savings with enterprise modernization Areas of net savings • Technology modernization 1 $1.5B-$2.0B − Rationalization − Centers of excellence • Productivity improvements 1 − Optimize call centers $900M-$1.1B − Vendor management − Business initiatives 1 $400M-$600M Projected costs to achieve • Operating expenses 1 − $200M-$300M annually through 2022 2020P 2021P Run Rate 2022P Modernization net savings are incremental to previously disclosed cost reduction programs 7 3. TRANSFORMATION Driving long-term value through transformation Medical cost Membership Expanded use of Increased customer Open platform savings growth CVS assets satisfaction and and new retention businesses Commercial insured Plan sponsors Pharmacy Improving the Payor agnostic consumer experience solutions Medicare Advantage Medicare Advantage MinuteClinic® members Data and Front of store analytics products Coram New businesses Medicare Advantage quality improvement Projected to drive ~$850M of incremental operating income in 2022, growing to ~$2.5B long term1 8 Substantial long-term value creation through strategic initiatives & consumer-centric products $1.5B - $2.0B ~$900M ~$850M Projected to drive a run rate of ~$3.5B in operating income in 20221 1. Integration 2. Enterprise 3. Transformation synergies modernization 9 Agenda 2019 guidance review Value creation through integration synergies, modernization & transformation Financial outlook & capital allocation strategy 10 Balancing near-term execution with long- term vision 1 2 3 4 5 6 Mitigate Execute Focus on Refine and Optimize Enhance headwinds streamlining integration roll out new enterprise shareholder and expense process and front doors to portfolio and returns through reduction exceed synergy health care evaluate asset disciplined